The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global In Vitro Diagnostics (IVD) Market Research Report 2024

Global In Vitro Diagnostics (IVD) Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1907935

No of Pages : 82

Ask Your Query

Synopsis

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.

The global In Vitro Diagnostics (IVD) market was valued at US$ 919.9 million in 2023 and is anticipated to reach US$ 1530.1 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for In Vitro Diagnostics (IVD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Diagnostics (IVD).

Report Scope

The In Vitro Diagnostics (IVD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vitro Diagnostics (IVD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the In Vitro Diagnostics (IVD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Pfizer
  • Thermo Fisher Scientific
  • Abbott
  • Biomerieux
  • Danaher Corporation
  • F. Hoffmann-La Roche
  • Becton Dickinson and Company
  • Bio-Rad Laboratories
  • Bayer AG
  • Sysmex Corporation
  • Johnson & Johnson
  • Hologic Inc
  • NEC Corp
  • Simens Healthcare

Segment by Type

  • Reagents
  • Instruments
  • Software and Services

Segment by Application

  • Standalone Laboratory
  • Hospitals
  • Academic and Medical Schools
  • Point of Care Testing
  • Others

By Region

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Diagnostics (IVD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Diagnostics (IVD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Reagents
1.2.3 Instruments
1.2.4 Software and Services
1.3 Market by Application
1.3.1 Global In Vitro Diagnostics (IVD) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Standalone Laboratory
1.3.3 Hospitals
1.3.4 Academic and Medical Schools
1.3.5 Point of Care Testing
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Diagnostics (IVD) Market Perspective (2019-2030)
2.2 In Vitro Diagnostics (IVD) Growth Trends by Region
2.2.1 Global In Vitro Diagnostics (IVD) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In Vitro Diagnostics (IVD) Historic Market Size by Region (2019-2024)
2.2.3 In Vitro Diagnostics (IVD) Forecasted Market Size by Region (2025-2030)
2.3 In Vitro Diagnostics (IVD) Market Dynamics
2.3.1 In Vitro Diagnostics (IVD) Industry Trends
2.3.2 In Vitro Diagnostics (IVD) Market Drivers
2.3.3 In Vitro Diagnostics (IVD) Market Challenges
2.3.4 In Vitro Diagnostics (IVD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Diagnostics (IVD) Players by Revenue
3.1.1 Global Top In Vitro Diagnostics (IVD) Players by Revenue (2019-2024)
3.1.2 Global In Vitro Diagnostics (IVD) Revenue Market Share by Players (2019-2024)
3.2 Global In Vitro Diagnostics (IVD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro Diagnostics (IVD) Revenue
3.4 Global In Vitro Diagnostics (IVD) Market Concentration Ratio
3.4.1 Global In Vitro Diagnostics (IVD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostics (IVD) Revenue in 2023
3.5 In Vitro Diagnostics (IVD) Key Players Head office and Area Served
3.6 Key Players In Vitro Diagnostics (IVD) Product Solution and Service
3.7 Date of Enter into In Vitro Diagnostics (IVD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Diagnostics (IVD) Breakdown Data by Type
4.1 Global In Vitro Diagnostics (IVD) Historic Market Size by Type (2019-2024)
4.2 Global In Vitro Diagnostics (IVD) Forecasted Market Size by Type (2025-2030)
5 In Vitro Diagnostics (IVD) Breakdown Data by Application
5.1 Global In Vitro Diagnostics (IVD) Historic Market Size by Application (2019-2024)
5.2 Global In Vitro Diagnostics (IVD) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In Vitro Diagnostics (IVD) Market Size (2019-2030)
6.2 North America In Vitro Diagnostics (IVD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In Vitro Diagnostics (IVD) Market Size by Country (2019-2024)
6.4 North America In Vitro Diagnostics (IVD) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Diagnostics (IVD) Market Size (2019-2030)
7.2 Europe In Vitro Diagnostics (IVD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In Vitro Diagnostics (IVD) Market Size by Country (2019-2024)
7.4 Europe In Vitro Diagnostics (IVD) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Diagnostics (IVD) Market Size (2019-2030)
8.2 Asia-Pacific In Vitro Diagnostics (IVD) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In Vitro Diagnostics (IVD) Market Size by Region (2019-2024)
8.4 Asia-Pacific In Vitro Diagnostics (IVD) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Diagnostics (IVD) Market Size (2019-2030)
9.2 Latin America In Vitro Diagnostics (IVD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In Vitro Diagnostics (IVD) Market Size by Country (2019-2024)
9.4 Latin America In Vitro Diagnostics (IVD) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Diagnostics (IVD) Market Size (2019-2030)
10.2 Middle East & Africa In Vitro Diagnostics (IVD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In Vitro Diagnostics (IVD) Market Size by Country (2019-2024)
10.4 Middle East & Africa In Vitro Diagnostics (IVD) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer In Vitro Diagnostics (IVD) Introduction
11.1.4 Pfizer Revenue in In Vitro Diagnostics (IVD) Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Introduction
11.2.4 Thermo Fisher Scientific Revenue in In Vitro Diagnostics (IVD) Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott In Vitro Diagnostics (IVD) Introduction
11.3.4 Abbott Revenue in In Vitro Diagnostics (IVD) Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Biomerieux
11.4.1 Biomerieux Company Detail
11.4.2 Biomerieux Business Overview
11.4.3 Biomerieux In Vitro Diagnostics (IVD) Introduction
11.4.4 Biomerieux Revenue in In Vitro Diagnostics (IVD) Business (2019-2024)
11.4.5 Biomerieux Recent Development
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Detail
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation In Vitro Diagnostics (IVD) Introduction
11.5.4 Danaher Corporation Revenue in In Vitro Diagnostics (IVD) Business (2019-2024)
11.5.5 Danaher Corporation Recent Development
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Company Detail
11.6.2 F. Hoffmann-La Roche Business Overview
11.6.3 F. Hoffmann-La Roche In Vitro Diagnostics (IVD) Introduction
11.6.4 F. Hoffmann-La Roche Revenue in In Vitro Diagnostics (IVD) Business (2019-2024)
11.6.5 F. Hoffmann-La Roche Recent Development
11.7 Becton Dickinson and Company
11.7.1 Becton Dickinson and Company Company Detail
11.7.2 Becton Dickinson and Company Business Overview
11.7.3 Becton Dickinson and Company In Vitro Diagnostics (IVD) Introduction
11.7.4 Becton Dickinson and Company Revenue in In Vitro Diagnostics (IVD) Business (2019-2024)
11.7.5 Becton Dickinson and Company Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Detail
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Introduction
11.8.4 Bio-Rad Laboratories Revenue in In Vitro Diagnostics (IVD) Business (2019-2024)
11.8.5 Bio-Rad Laboratories Recent Development
11.9 Bayer AG
11.9.1 Bayer AG Company Detail
11.9.2 Bayer AG Business Overview
11.9.3 Bayer AG In Vitro Diagnostics (IVD) Introduction
11.9.4 Bayer AG Revenue in In Vitro Diagnostics (IVD) Business (2019-2024)
11.9.5 Bayer AG Recent Development
11.10 Sysmex Corporation
11.10.1 Sysmex Corporation Company Detail
11.10.2 Sysmex Corporation Business Overview
11.10.3 Sysmex Corporation In Vitro Diagnostics (IVD) Introduction
11.10.4 Sysmex Corporation Revenue in In Vitro Diagnostics (IVD) Business (2019-2024)
11.10.5 Sysmex Corporation Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Detail
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson In Vitro Diagnostics (IVD) Introduction
11.11.4 Johnson & Johnson Revenue in In Vitro Diagnostics (IVD) Business (2019-2024)
11.11.5 Johnson & Johnson Recent Development
11.12 Hologic Inc
11.12.1 Hologic Inc Company Detail
11.12.2 Hologic Inc Business Overview
11.12.3 Hologic Inc In Vitro Diagnostics (IVD) Introduction
11.12.4 Hologic Inc Revenue in In Vitro Diagnostics (IVD) Business (2019-2024)
11.12.5 Hologic Inc Recent Development
11.13 NEC Corp
11.13.1 NEC Corp Company Detail
11.13.2 NEC Corp Business Overview
11.13.3 NEC Corp In Vitro Diagnostics (IVD) Introduction
11.13.4 NEC Corp Revenue in In Vitro Diagnostics (IVD) Business (2019-2024)
11.13.5 NEC Corp Recent Development
11.14 Simens Healthcare
11.14.1 Simens Healthcare Company Detail
11.14.2 Simens Healthcare Business Overview
11.14.3 Simens Healthcare In Vitro Diagnostics (IVD) Introduction
11.14.4 Simens Healthcare Revenue in In Vitro Diagnostics (IVD) Business (2019-2024)
11.14.5 Simens Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock